Complications revisited. The debit side of total hip replacement.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000601:surgery; D001178:Arthroplasty / Q000009:adverse effects*; D001241:Aspirin / Q000627:therapeutic use; D001843:Bone Cements; D003911:Dextrans / Q000627:therapeutic use; D005260:Female; D005271:Femur Head Necrosis / Q000601:surgery; D005500:Follow-Up Studies; D006406:Hematoma / Q000209:etiology / Q000517:prevention & control; D006615:Hip / Q000601:surgery*; D006617:Hip Dislocation / Q000209:etiology; D006621:Hip Joint; D006801:Humans; D017053:Infection Control; D007239:Infections / Q000209:etiology; D007595:Joint Prosthesis / Q000009:adverse effects*; D008297:Male; D009999:Ossification, Heterotopic / Q000209:etiology; D010003:Osteoarthritis / Q000601:surgery; D010523:Peripheral Nervous System Diseases / Q000209:etiology; D011183:Postoperative Complications; D013924:Thrombophlebitis / Q000209:etiology / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D001843:Bone Cements; D003911:Dextrans; D001241:Aspirin